Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
69.60
+0.40 (0.58%)
Nov 16, 2026, 5:35 PM CET
BME:ROVI Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 70.92 | 97.98 | 27.19 | 25.32 | 124.95 | 99.04 |
Short-Term Investments | - | 0.62 | 0.83 | 0.11 | 0.09 | 0.1 |
Cash & Short-Term Investments | 70.92 | 98.6 | 28.02 | 25.44 | 125.03 | 99.14 |
Cash Growth | 43.99% | 251.93% | 10.15% | -79.66% | 26.13% | 86.22% |
Accounts Receivable | 247.58 | 163.31 | 114.83 | 124.55 | 160.23 | 129.8 |
Other Receivables | 0.11 | 12.04 | 12.61 | 15.91 | 21.06 | 27.83 |
Receivables | 247.69 | 175.36 | 127.44 | 140.46 | 181.28 | 157.63 |
Inventory | 244.59 | 287.98 | 329.95 | 337.97 | 311.94 | 245.47 |
Prepaid Expenses | 5.06 | 3.19 | 2.69 | 2.73 | 2.03 | 1.79 |
Other Current Assets | - | 1.59 | 1.51 | 2.74 | 2.79 | 2.33 |
Total Current Assets | 568.25 | 566.71 | 489.61 | 509.33 | 623.07 | 506.36 |
Property, Plant & Equipment | 496.25 | 330.74 | 286.62 | 253.65 | 215.54 | 181.78 |
Long-Term Investments | 19.31 | 19.16 | 19.52 | 0.59 | 2.2 | 2.07 |
Goodwill | 2.7 | 2.7 | - | - | - | - |
Other Intangible Assets | 32.9 | 33.18 | 33.95 | 27.74 | 29.14 | 31.51 |
Long-Term Deferred Tax Assets | 17.38 | 3.2 | 2.26 | 2.34 | 2.08 | 3.85 |
Long-Term Deferred Charges | - | - | - | 6.16 | 6.6 | 7.05 |
Other Long-Term Assets | - | - | 0.07 | 0.07 | 0.07 | 0.07 |
Total Assets | 1,137 | 955.69 | 832.02 | 799.88 | 878.7 | 732.68 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 120.28 | 84.75 | 89.93 | 109.89 | 125.87 | 99.4 |
Accrued Expenses | - | 30.23 | 33.19 | 28.83 | 31.67 | 24.6 |
Current Portion of Long-Term Debt | 27.06 | 22.26 | 17.84 | 8.06 | 8.27 | 2.98 |
Current Portion of Leases | - | 6.36 | 5.85 | 5.13 | 4.46 | 3.44 |
Current Income Taxes Payable | 31.76 | 4.4 | 2.38 | 5.26 | - | 0.68 |
Current Unearned Revenue | 32.92 | 29.64 | 5.25 | 39.51 | 115.39 | 58.12 |
Other Current Liabilities | - | 3.58 | 2.21 | 3.17 | 8.23 | 1.17 |
Total Current Liabilities | 212.02 | 181.22 | 156.65 | 199.84 | 293.89 | 190.39 |
Long-Term Debt | 62.76 | 83.88 | 80.5 | 38.58 | 46.04 | 52.52 |
Long-Term Leases | 11.12 | 9.33 | 10.22 | 13.67 | 13.4 | 14.22 |
Long-Term Unearned Revenue | 30.7 | 5.46 | 2.75 | 2.79 | 3.32 | 3.79 |
Long-Term Deferred Tax Liabilities | 21.57 | 0.16 | 0.37 | 1.52 | 0.68 | 0.78 |
Other Long-Term Liabilities | 0.2 | 0.19 | - | - | - | - |
Total Liabilities | 338.38 | 280.24 | 250.48 | 256.39 | 357.32 | 261.7 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.07 | 3.07 | 3.07 | 3.24 | 3.24 | 3.36 |
Additional Paid-In Capital | 87.64 | 87.64 | 87.64 | 87.64 | 87.64 | 87.64 |
Retained Earnings | 692.24 | 578.93 | 486.89 | 556.21 | 456.7 | 446.1 |
Treasury Stock | -5.47 | -5.17 | -5.55 | -107.68 | -27.56 | -66.12 |
Comprehensive Income & Other | 2.31 | -0.05 | -0.02 | -0.02 | -0.01 | -0 |
Total Common Equity | 779.79 | 664.42 | 572.03 | 539.39 | 520.01 | 470.98 |
Minority Interest | 18.62 | 11.04 | 9.51 | 4.11 | 1.37 | - |
Shareholders' Equity | 798.41 | 675.46 | 581.54 | 543.49 | 521.38 | 470.98 |
Total Liabilities & Equity | 1,137 | 955.69 | 832.02 | 799.88 | 878.7 | 732.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 100.95 | 121.82 | 114.41 | 65.43 | 72.17 | 73.16 |
Net Cash (Debt) | -30.03 | -23.22 | -86.39 | -39.99 | 52.87 | 25.97 |
Net Cash Growth | - | - | - | - | 103.55% | - |
Net Cash Per Share | -0.59 | -0.45 | -1.69 | -0.75 | 0.99 | 0.47 |
Filing Date Shares Outstanding | 51.14 | 51.15 | 51.15 | 51.82 | 53.37 | 54.85 |
Total Common Shares Outstanding | 51.14 | 51.15 | 51.15 | 51.82 | 53.37 | 54.85 |
Working Capital | 356.23 | 385.49 | 332.96 | 309.49 | 329.19 | 315.97 |
Book Value Per Share | 15.25 | 12.99 | 11.18 | 10.41 | 9.74 | 8.59 |
Tangible Book Value | 744.19 | 628.53 | 538.08 | 511.65 | 490.87 | 439.46 |
Tangible Book Value Per Share | 14.55 | 12.29 | 10.52 | 9.87 | 9.20 | 8.01 |
Land | - | 81.79 | 74.8 | 60.65 | 45.12 | 37.25 |
Machinery | - | 445.19 | 404.19 | 372.97 | 303.78 | 275.44 |
Construction In Progress | - | 22.09 | 11.01 | 8.47 | 40.17 | 28.06 |